ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports ...

Diagnostic delays in narcolepsy and idiopathic hypersomnia (IH) persist largely because of low awareness among patients, ...

Welcome back to another AJMC Stakeholder Summit series. In "Vitiligo Prevalence and Why It Isn't Cosmetic," moderator Susan ...

FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase ...

Nearly 3 in 4 adults undergoing metabolic bariatric surgery (MBS) at 4 international centers met criteria for clinical ...

Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new ...

Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise ...

OneOncology's Larry Bilbrey explains how to guide practices on AI without endorsing products and why technology gaps outweigh ...

The FDA approved satralizumab-mwge (Enspryng; Genentech) on October 15, 2026, for adults with thyroid eye disease (TED) ...

Recent ENDURANCE data support 2-year lenalidomide maintenance in standard-risk multiple myeloma and individualize when to stop.

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...